Literature DB >> 17202217

The level of viral antigen presented by hepatocytes influences CD8 T-cell function.

Adam J Gehring1, Dianxing Sun, Patrick T F Kennedy, Esther Nolte-'t Hoen, Seng Gee Lim, Shanthi Wasser, Clare Selden, Mala K Maini, Dan M Davis, Michael Nassal, Antonio Bertoletti.   

Abstract

CD8 T cells exert their antiviral function through cytokines and lysis of infected cells. Because hepatocytes are susceptible to noncytolytic mechanisms of viral clearance, CD8 T-cell antiviral efficiency against hepatotropic viruses has been linked to their capacity to produce gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). On the other hand, intrahepatic cytokine production triggers the recruitment of mononuclear cells, which sustain acute and chronic liver damage. Using virus-specific CD8 T cells and human hepatocytes, we analyzed the modulation of virus-specific CD8 T-cell function after recognition peptide-pulsed or virally infected hepatocytes. We observed that hepatocyte antigen presentation was generally inefficient, and the quantity of viral antigen strongly influenced CD8 T-cell antiviral function. High levels of hepatitis B virus production induced robust IFN-gamma and TNF-alpha production in virus-specific CD8 T cells, while limiting amounts of viral antigen, both in hepatocyte-like cells and naturally infected human hepatocytes, preferentially stimulated CD8 T-cell degranulation. Our data document a mechanism where virus-specific CD8 T-cell function is influenced by the quantity of virus produced within hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202217      PMCID: PMC1866017          DOI: 10.1128/JVI.02415-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Authors:  S L Tsai; P J Chen; M Y Lai; P M Yang; J L Sung; J H Huang; L H Hwang; T H Chang; D S Chen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.

Authors:  F Birnbaum; M Nassal
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Expression of HLA class I antigens on hepatocytes in liver disease.

Authors:  T Fukusato; M A Gerber; S N Thung; S Ferrone; F Schaffner
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

5.  Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.

Authors:  Dianxing Sun; Michael Nassal
Journal:  J Hepatol       Date:  2006-07-07       Impact factor: 25.083

6.  In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens.

Authors:  J J van den Oord; R de Vos; V J Desmet
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

7.  Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.

Authors:  M Sällberg; U Rudén; L O Magnius; H P Harthus; M Noah; B Wahren
Journal:  J Med Virol       Date:  1991-04       Impact factor: 2.327

8.  Detection of widespread hepatocyte infection in chronic hepatitis C.

Authors:  V Agnello; G Abel; G B Knight; E Muchmore
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement.

Authors:  A R Jilbert; T T Wu; J M England; P M Hall; N Z Carp; A P O'Connell; W S Mason
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.

Authors:  A J Strain; T Ismail; H Tsubouchi; N Arakaki; T Hishida; N Kitamura; Y Daikuhara; P McMaster
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

View more
  36 in total

1.  Review.

Authors:  Christopher B O'Brien
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

Review 2.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

Review 3.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

4.  Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression.

Authors:  Daniel Kim; Kwang Soo Lyoo; Davey Smith; Wonhee Hur; Sung Woo Hong; Pil Soo Sung; Seung Kew Yoon; Sanjay Mehta
Journal:  J Med Virol       Date:  2011-12       Impact factor: 2.327

5.  Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner.

Authors:  Sandra Boswell; Shayan Sharif; Akeel Alisa; Stephen P Pereira; Roger Williams; Shahriar Behboudi
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

6.  Chronically inflamed livers up-regulate expression of inhibitory B7 family members.

Authors:  Rachel Kassel; Michael W Cruise; Julia C Iezzoni; Nicholas A Taylor; Timothy L Pruett; Young S Hahn
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

7.  Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system.

Authors:  John R Lukens; Joseph S Dolina; Taeg S Kim; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

Review 8.  Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection.

Authors:  Yuejin Liang; Zakari Kwota; Jiaren Sun
Journal:  Int Immunopharmacol       Date:  2016-07-25       Impact factor: 4.932

9.  Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Authors:  Anthony Tanoto Tan; Elisabetta Loggi; Carolina Boni; Adeline Chia; Adam J Gehring; Konduru S R Sastry; Vera Goh; Paola Fisicaro; Pietro Andreone; Christian Brander; Seng Gee Lim; Carlo Ferrari; Florian Bihl; Antonio Bertoletti
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China.

Authors:  Xinxing Yang; Youhua Hao; Zhi Liu; Ling Chen; Honghui Ding; Xiping Zhao; Mengji Lu; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.